OsteopathyPreTerm NeonateSensory ProfilesColicSleep QualityMotor Development of Premature Infants
Investigational drug(s) / intervention(s)
Osteopathic interventionHome based exercise education
Osteopathic intervention: Researcher will use osteopathic techniques on cranial area includes light touch.
Home based exercises will be show on cases and demand to do exercise regularly
Home based exercise education: Home based exercises will be show on cases and demand to do exercise regularly.
Study summary
There are planing to have 2 groups of premature born cases. Each group will include 15 cases. Participants are need to be 28-37 weeks born and no older than post term 6 weeks. All cases are going to be evaluated. Home based exercise plan is going to be explained. The experimental group is going to take 6 osteopathic sessions weekly. After 6 weeks cases are going to be evaluated again.
Eligibility
Sex
ALL
Min age
1 Week
Max age
6 Weeks
Healthy volunteers
Accepted
Inclusion Criteria:
* Premature birth (\<37 weeks)
* Corrected age \<6 weeks.
* Discharged to home
* Stable condition
* Family agrees to continue home program
Exclusion Criteria:
* Having a congenital cyanotic heart problem,
* Being born earlier than 28 weeks,
* The family not accepting to participate in the study,
* Neglecting check-ups and sessions,
* Using a respiratory appliance,
* Presence of craniosynostosis,
* Being included in another physiotherapy program during the study period
Primary outcome measure(s)
Test of Infant Motor Performance — 6 weeks The test is a motor outcome measure designed to assess posture and selective control of movement in infants for functional performance in daily life. The test consists of 31 items in standard format, 28 of which are made by observing spontaneous activities and scoring them as pass or fail. Getting higher points means better motor control.
Trial sites (1)
Facility
City
Region
Status
Bahriye Baş
Bursa
Osmangazi
More Abant Izzet Baysal University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.